According to Cosmo Pharmaceuticals's latest financial reports the company's current EPS (TTM) is 1,07ย โฌ. In 2022 the company made an earnings per share (EPS) of 1,07ย โฌ a decrease over its 2021 EPS that were of 1,38ย โฌ.